Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27479414 | 0.93 | DNM1 (0.43) | DNM1ALDH1A1CA1CA2 | |
| SCHEMBL31296272 | 0.92 | ADRB2 (0.38) | ADRB2ADRB1ADRB3DNM1CYP3A4 | |
| SCHEMBL27478603 | 0.91 | DNM1 (0.47) | DNM1TSHR | |
| SCHEMBL8114496 | 0.90 | ADRB2 (0.36) | ADRB2ADRB1ADRB3DNM1CYP3A4 | |
| SCHEMBL8099033 | 0.84 | — | — | |
| SCHEMBL22445640 | 0.84 | TSHR (0.39) | DNM1TSHRALDH1A1 | |
| SCHEMBL27324872 | 0.84 | DNM1 (0.32) | ADRB2ADRB1ADRB3DNM1 | |
| SCHEMBL27808679 | 0.83 | DNM1 (0.43) | DNM1ALDH1A1 | |
| SCHEMBL28619798 | 0.82 | TSHR (0.41) | ADRB2ADRB1ADRB3DNM1CYP3A4 | |
| SCHEMBL21331540 | 0.82 | DNM1 (0.31) | DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115850025-A | Method for dechlorinating polyvinyl chloride and preparing micromolecular chlorohydrocarbon | 华东理工大学 | 2023-03-28 | — | — | CN | disclosed |
| CN-1143858-C | 6, 9-disubstituted 2- [ trans- (aminocyclohexyl) amino ] purines, compositions and uses thereof | ������ҩ������˾ | 2004-03-31 | — | — | CN | disclosed |
| EP-1056744-A1 | 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES | Aventis Pharmaceuticals Inc. (US) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999043675-A1 | 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES | AVENTIS PHARMACEUTICALS INC. (US) | 1999-09-02 | — | — | WO | disclosed |
| EP-0767768-B1 | HALOALKYLATION PROCESS | ALBEMARLE CORP (US) | 1999-03-31 | — | — | EP | disclosed |
| EP-0767768-A1 | HALOALKYLATION PROCESS | ALBEMARLE CORPORATION (US) | 1997-04-16 | — | — | EP | disclosed |
| WO-1996000202-A1 | HALOALKYLATION PROCESS | ALBEMARLE CORPORATION (US) | 1996-01-04 | — | — | WO | disclosed |
| US-5475170-A | Haloalkylation process | ALBERMARLE CORPORATION (US) | 1995-12-12 | — | — | US | disclosed |
| US-5319150-A | Chloroalkylation of aromatic compounds | ALBEMARLE CORPORATION (US) | 1994-06-07 | — | — | US | disclosed |
| US-5136115-A | BROMOALKYLATION OF AROMATIC COMPOUNDS | ALBERMARLE CORPORATION | 1992-08-04 | — | — | US | disclosed |
| EP-0369728-A1 | Haloalkylation of aromatic compounds | ETHYL CORPORATION (US) | 1990-05-23 | — | — | EP | disclosed |